...
首页> 外文期刊>BMC Genomics >Nur77-deficiency in bone marrow-derived macrophages modulates inflammatory responses, extracellular matrix homeostasis, phagocytosis and tolerance
【24h】

Nur77-deficiency in bone marrow-derived macrophages modulates inflammatory responses, extracellular matrix homeostasis, phagocytosis and tolerance

机译:骨髓来源的巨噬细胞中的Nur77缺乏调节炎症反应,细胞外基质稳态,吞噬作用和耐受性

获取原文
           

摘要

Background The nuclear orphan receptor Nur77 (NR4A1, TR3, or NGFI-B) has been shown to modulate the inflammatory response of macrophages. To further elucidate the role of Nur77 in macrophage physiology, we compared the transcriptome of bone marrow-derived macrophages (BMM) from wild-type (WT) and Nur77-knockout (KO) mice. Results In line with previous observations, SDF-1α (CXCL12) was among the most upregulated genes in Nur77-deficient BMM and we demonstrated that Nur77 binds directly to the SDF-1α promoter, resulting in inhibition of SDF-1α expression. The cytokine receptor CX3CR1 was strongly downregulated in Nur77-KO BMM, implying involvement of Nur77 in macrophage tolerance. Ingenuity pathway analyses (IPA) to identify canonical pathways regulation and gene set enrichment analyses (GSEA) revealed a potential role for Nur77 in extracellular matrix homeostasis. Nur77-deficiency increased the collagen content of macrophage extracellular matrix through enhanced expression of several collagen subtypes and diminished matrix metalloproteinase (MMP)-9 activity. IPA upstream regulator analyses discerned the small GTPase Rac1 as a novel regulator of Nur77-mediated gene expression. We identified an inhibitory feedback loop with increased Rac1 activity in Nur77-KO BMM, which may explain the augmented phagocytic activity of these cells. Finally, we predict multiple chronic inflammatory diseases to be influenced by macrophage Nur77 expression. GSEA and IPA associated Nur77 to osteoarthritis, chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, and allergic airway inflammatory diseases. Conclusions Altogether these data identify Nur77 as a modulator of macrophage function and an interesting target to treat chronic inflammatory disease.
机译:背景技术核孤儿受体Nur77(NR4A1,TR3或NGFI-B)已被证明可调节巨噬细胞的炎症反应。为了进一步阐明Nur77在巨噬细胞生理中的作用,我们比较了野生型(WT)和Nur77敲除(KO)小鼠的骨髓巨噬细胞(BMM)的转录组。结果与以前的观察结果一致,SDF-1α(CXCL12)是Nur77缺陷型BMM中表达最上调的基因之一,我们证明Nur77直接与SDF-1α启动子结合,从而抑制了SDF-1α表达。在Nur77-KO BMM中,细胞因子受体CX3CR1被强烈下调,这暗示Nur77参与巨噬细胞耐受性。鉴定经典途径调控的机能途径分析(IPA)和基因组富集分析(GSEA)显示Nur77在细胞外基质稳态中的潜在作用。 Nur77缺乏症通过增强几种胶原亚型的表达和减少基质金属蛋白酶(MMP)-9活性来增加巨噬细胞胞外基质的胶原蛋白含量。 IPA上游调节剂分析发现,小GTPase Rac1是Nur77介导的基因表达的新型调节剂。我们在Nur77-KO BMM中鉴定出具有增加的Rac1活性的抑制性反馈环,这可能解释了这些细胞的吞噬活性增强。最后,我们预测巨噬细胞Nur77表达会影响多种慢性炎症性疾病。 GSEA和IPA将Nur77与骨关节炎,慢性阻塞性肺疾病,类风湿性关节炎,牛皮癣和过敏性气道炎性疾病相关。结论总而言之,这些数据确定Nur77是巨噬细胞功能的调节剂,并且是治疗慢性炎性疾病的有趣靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号